The USA Stroke Management Interventional landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook (2021-2026)
The USA Stroke management report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with performing physicians in Interventional Radiology/Radiology, Interventional Neurology and Neurosurgery departments from academic/university hospitals, community teaching hospitals, non-teaching hospitals, and private practice in the USA.
The report covers:
Endovascular therapy (EVT) interventions: for ischemic and hemorrhagic stroke.
Neuro thrombectomy device: stent retrievers with coil or clamp, balloon guiding catheters, aspiration devices, and microcatheters.
Procedure trends: by stages of the disease, artery location, performing departments, route of access used for the intervention, and type of interventions
Insights on reimbursement such as the variance of insurance coverage for Stroke procedures across provinces and cities based on the type of insurance, physician treatment selection criteria, current and upcoming policies for diagnosis and treatment are delved into.
Physician’s brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others affecting brand usage have been covered.
Future trends such as new developments in recanalization therapy with the combination use of stent retrievers, balloon guiding catheters, and aspiration devices such as in Solumbra technique in addition to Direct Aspiration First Pass Technique (ADAPT) and Stent Retriever Assisted Vacuum-Locked Extraction (SAVE) technique. The introduction of 3rd gen of stent retrievers with self-expandable design-focus innovations to achieve higher clot retrieval rate and novel technology of cyclical aspiration pumps for removal of clots continuously are potential game-changers to watch out for in the growing neuro thrombectomy devices market.
Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as FDA approval of IpsiHand Rehabilitation Device by Neurolutions and Vivistim Paired VNS system by MicroTransponder for stroke survivors are covered in the report
What’s in it for you?
This report will help Stroke interventional device companies understand the Stroke intervention landscape, procedural and technology trends, and the brand perception and competitive intelligence in the USA.
The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the Stroke interventional devices market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model. REPORT COST: 5,000 USD
Contact us below for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.